Found this by chance; and I posted it on ITT FB page.
The video of NHSE board meeting discussing the Consultation findings, starting at 52mins. Sir Bruce Keough tries to summarise: "all around the NHS there are endeavours to deal with efficiency, cost effectiveness and value for taxpayers and patients.... ROUTINE prescribing - this is not a ban on medications, in medicine it is dangerous to ever say never.... L-thyroxine (T3) is an expensive version of thyroxine..." 😮😡. Someone asked 'over 2,000 of the 2,600 respondents were female, is there an issue around inequality?' BK: "Nothing there gives me concern." Then: 'Approval of recommendations for 18 items considered to be relatively ineffective, unnecessary, inappropriate or unsafe.' So at the board meeting, Liothyronine was not understood by the board, or even by Sir Bruce Keough.
So the NHSE Board weren't aware of what T3 is. Give me strength.
ITT members were shocked at the ineptitude, to say the least.
Can we ask for another consultation, like a second referendum on Brexit?!